[Use of flunarizine in mild-to-severe senile cerebral deterioration].
Within the framework of multifactorial etiology the use of calcium entry blockers as a complementary measure in the management of moderate-to-severe senile brain deterioration has been studied. Clinical study of twelve flunarizine-treated patients has yielded promising evidence in favor of vasoactive drugs as adjuvants to treatment with psychoactive drugs. Further studies should lend support to this hypothesis.
Fasullo
S
S
Università degli Studi di Palermo Cattedra R di Clinica Psichiatrica.
Cordovana
V
V
D000368:Aged; D003704:Dementia / Q000188:drug therapy*; D004341:Drug Evaluation; D005444:Flunarizine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011569:Psychiatric Status Rating Scales; D013997:Time Factors
D005444:Flunarizine
Studio sull'impiego della flunarizina nel deterioramento cerebrale senile di grado medio-lieve.